Superworth

Solventum profit margin SOLV

Gross, operating and net profit as a share of revenue over the last twelve months, from 2023.

Net margin, 12 months
17.3%
Operating margin, 12 months
25.0%
Net margin on a year earlier
+12.7 pts
Peer median
12.9%

Over the twelve months to Jun 30, 2026, Solventum kept 17.3% of its revenue as net profit, with an operating margin of 25.0% and a gross margin of 54.7%.

The median for 10 medical instruments and supplies stocks of a similar size is 12.9%.

Profit margin over time

GrossOperatingNet

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearNet marginOperating marginGross margin
FY202518.7%26.2%53.5%
FY20245.8%12.6%55.6%
FY202316.4%20.6%57.3%

Quarter by quarter

QuarterEndedNet margin, 12 monthsChange on a yearOperating margin
Q2 FY2617.3%+12.7 pts25.0%
Q1 FY2617.3%+12.8 pts25.5%
Q4 FY2518.7%+12.9 pts26.2%
Q3 FY2518.1%+9.4 pts26.1%
Q2 FY254.5%−8.4 pts9.3%
Q1 FY254.6%−11.2 pts9.7%
Q4 FY245.8%−10.6 pts12.6%
Q3 FY248.8%n/a15.9%
Q2 FY2412.9%n/a18.7%
Q1 FY2415.7%n/a20.8%
Q4 FY2316.4%n/a20.6%
Q3 FY23n/an/an/a

Against its peers

Companies in Medical - Instruments & Supplies nearest Solventum's size, closest first, today.

CompanyProfit margin
SOLVSolventum17.3%
PENPenumbra10.7%
COOCooper Companies13.5%
ALGNAlign Technology10.0%
GMEDGlobus Medical17.0%
PODDInsulet12.3%
WSTWest Pharmaceutical Services17.0%
MSAMSA Safety16.1%
RMDResMed26.9%
MMSIMerit Medical Systems9.2%
HAEHaemonetics7.1%
Peer median12.9%

Where Solventum ranks

What the profit margin tells you

Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).

Compare within an industry. 10% is superb for a retailer and poor for a software company.

More on Solventum

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.